Birlasoft
- Market cap
- ₹ 8,493 Cr.
- P/E
- 14.2x
- P/B
- 2.13x
- 52-week range
- 267.05 – 474
- ROE
- 14%
- ROCE
- 21%
- Dividend yield
- 2.1%
- Debt / equity
- 0.03
- Sector
- IT - Software
- Industry
- Computers - Software & Consulting
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Computers - Software & Consulting: 108 companies →Birlasoft against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)14.2 against a typical 21.9: cheaper than most peers (1st = cheapest).32nd of 108
- Sales growth+7.3% against a typical +10.6% from a year earlier.55th of 90
- Profit growth+51.9% against a typical +1.1% from a year earlier.17th of 75
- Share price, 3 months−0.6% against a typical −8.4%.36th of 97
- Size₹ 8,492.6 Cr. market value against a typical ₹ 218.6 Cr. (1st = largest).15th of 101
Latest announcements
Exchange filings and their impact on the company.
- Birlasoft named OpenAI Select Partner to build and scale enterprise AI solutions.
Birlasoft on October 8, 2026 said it has been named an OpenAI Select Partner within the OpenAI Partner Network to build, sell and deliver AI solutions with OpenAI. The company will co-work with OpenAI to deploy solutions using GPT-6 Astra across manufacturing, life sciences, energy and utilities and other verticals, citing client outcomes like 20-30% faster asset health acknowledgement and up to 85% faster query response. It plans to expand OpenAI-related offerings and invest in talent and new solutions to scale customer deployments.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA+ by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE AA+ | Stable | 24 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Reaffirmed | CARE AA+ | — | CARE | ₹ 352 Cr. | |
| 24 Sep 2025 | Reaffirmed | CARE AA+ | — | CARE | ₹ 352 Cr. |
Research by Minerva Capital Research Solutions
Our research team's work on BirlasoftAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 28 Oct 2026Upcoming | Financial Results/Dividend | To consider and approve:a) the unaudited financial results (Standalone and Consolidated) of the Company, for the quarter and half-year ended September 30, 2026; andb) declaration of interim dividend for the financial year 2026-27. |
| 28 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 6 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 28 Jan 2026 | Financial Results | To consider and approve the unaudited financial results (Standalone and Consolidated) of the Company, for the quarter and nine months ended December 31, 2025 |
| 6 Nov 2025 | Financial Results/Dividend | To consider and approve: a) the unaudited financial results (Standalone and Consolidated) of the Company, for the quarter and half-year ended September 30, 2025; andb) declaration of interim dividend for the financial year 2025-26. |
| 7 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 28 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,310 | 1,343 | 1,363 | 1,327 | 1,368 | 1,363 | 1,317 | 1,285 | 1,329 | 1,348 | 1,349 | 1,379 |
| Expenses | 1,103 | 1,129 | 1,141 | 1,132 | 1,203 | 1,199 | 1,143 | 1,126 | 1,116 | 1,103 | 1,099 | 1,157 |
| Operating Profit | 207 | 214 | 222 | 195 | 165 | 163 | 174 | 159 | 213 | 245 | 249 | 223 |
| OPM % | 16% | 16% | 16% | 15% | 12% | 12% | 13% | 12% | 16% | 18% | 18% | 16% |
| Other Income | 16 | 28 | 46 | 35 | 33 | 21 | 20 | 33 | 22 | −27 | −4 | 29 |
| Interest | 6 | 6 | 4 | 4 | 7 | 7 | 6 | 5 | 5 | 6 | 4 | 4 |
| Depreciation | 22 | 21 | 21 | 21 | 22 | 21 | 22 | 21 | 20 | 20 | 19 | 19 |
| Profit before tax | 196 | 215 | 242 | 205 | 170 | 156 | 166 | 166 | 210 | 192 | 222 | 228 |
| Tax % | 26% | 25% | 26% | 27% | 25% | 25% | 27% | 36% | 45% | 37% | 21% | 29% |
| Net Profit | 145 | 161 | 180 | 150 | 128 | 117 | 122 | 106 | 116 | 120 | 176 | 161 |
| EPS in Rs | 5.27 | 5.84 | 6.53 | 5.44 | 4.61 | 4.23 | 4.39 | 3.83 | 4.17 | 4.3 | 6.29 | 5.76 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 5%
- 5 Years
- 8%
- 3 Years
- 3%
- TTM
- 1%
- 10 Years
- 6%
- 5 Years
- 11%
- 3 Years
- 18%
- TTM
- 26%
- 10 Years
- 14%
- 5 Years
- −6%
- 3 Years
- −13%
- TTM
- —
- 10 Years
- 16%
- 5 Years
- 17%
- 3 Years
- 17%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.